Amber McGraw Walsh

As the Chairwoman of the firm’s Healthcare Department, Amber Walsh chairs one of the largest healthcare practices in the United States and is a leader in promoting the advancement of women in the private equity sector.

Focusing her practice on corporate healthcare transactional work and regulatory matters, she represents healthcare providers such as hospitals, health systems, dialysis facilities, multi- and single-specialty medical practices, specialty hospitals, ambulatory surgery centers, and a variety of healthcare industry entrepreneurs, in sales and acquisitions, joint ventures, general corporate matters, contracting, securities, and regulatory matters.

Her work includes negotiating and drafting transaction documents and counseling clients with regard to the legal aspects of day-to-day operations, including general corporate matters; anti-kickback and Stark issues; self-referral, corporate practice of medicine and fee-splitting prohibitions; HIPAA, certificate of need and licensure requirements; and state and federal securities matters. In 2017, Amber was named to Mergers & Acquisitions magazine’s list of “The Most Influential Women in Mid-Market M&A.”

As one of the principal drivers behind McGuireWoods’ healthcare private equity initiatives, Amber co-chairs the firm’s annual Healthcare and Life Sciences Private Equity and Finance Conference, one of the largest private equity events in the U.S. healthcare market, which facilitates deals by connecting investors with surgery centers, dialysis facilities, physician practices and other industry players.

A recognized thought-leader in the healthcare/M&A and private equity arenas, Amber co-authors a regular Law360 column covering middle market healthcare and life sciences deals , co-writes McGuireWoods’ The Healthcare Investor blog, and is the lead author on a series which spotlights women private equity leaders.